Last reviewed · How we verify

NCT06846801

Balloon Dilation Under Portable X-ray System in the Treatment of Pharyngo-oesphageal Strictures

Active, enrolled NA Last updated 26 February 2025
What this trial tests

NA trial testing Balloon Dilation Under Portable X-ray System in Pharyngo-oesphageal Strictures in 20 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 November 2024
Primary endpoint
30 April 2025
30 May 2025

Quick facts

Lead sponsorMohammed Elrabie Ahmed
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 November 2024
Primary completion30 April 2025
Estimated completion30 May 2025
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mohammed Elrabie Ahmed

Who can join

Eligibility, any sex, with Pharyngo-oesphageal Strictures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study is to evaluate the outcomes (efficacy and safety) and to present our experience in X-DR portable x-ray system guided endoscopic balloon dilatation in the treatment of pharyngo-oesophageal strictures as an alternative procedure to the videofluroscopic guided maneuver.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Mohammed Elrabie Ahmed trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06846801.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing